» Articles » PMID: 20433747

NF-kappaB/STAT3/PI3K Signaling Crosstalk in IMyc E Mu B Lymphoma

Overview
Journal Mol Cancer
Publisher Biomed Central
Date 2010 May 4
PMID 20433747
Citations 70
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Myc is a well known driver of lymphomagenesis, and Myc-activating chromosomal translocation is the recognized hallmark of Burkitt lymphoma, an aggressive form of non-Hodgkin's lymphoma. We developed a model that mimics this translocation event by inserting a mouse Myc cDNA gene into the immunoglobulin heavy chain locus, just upstream of the intronic Emu enhancer. These mice, designated iMyc E mu, readily develop B-cell lymphoma. To study the mechanism of Myc-induced lymphoma, we analyzed signaling pathways in lymphoblastic B-cell lymphomas (LBLs) from iMyc E mu mice, and an LBL-derived cell line, iMyc E mu-1.

Results: Nuclear factor-kappaB (NF-kappaB) and signal transducer and activator of transcription 3 (STAT3) were constitutively activated in iMyc E mu mice, not only in LBLs but also in the splenic B-lymphocytes of young animals months before tumors developed. Moreover, inhibition of either transcription factor in iMyc E mu-1 cells suppressed growth and caused apoptosis, and the abrogation of NF-kappaB activity reduced DNA binding by both STAT3 and Myc, as well as Myc expression. Inhibition of STAT3 signaling eliminated the activity of both NF-kappaB and Myc, and resulted in a corresponding decrease in the level of Myc. Thus, in iMyc E mu-1 cells NF-kappaB and STAT3 are co-dependent and can both regulate Myc. Consistent with this, NF-kappaB and phosphorylated STAT3 were physically associated with one another. In addition, LBLs and iMyc E mu-1 cells also showed constitutive AKT phosphorylation. Blocking AKT activation by inhibiting PI3K reduced iMyc E mu-1 cell proliferation and caused apoptosis, via downregulation of NF-kappaB and STAT3 activity and a reduction of Myc levels. Co-treatment with NF-kappaB, STAT3 or/and PI3K inhibitors led to additive inhibition of iMyc E mu-1 cell proliferation, suggesting that these signaling pathways converge.

Conclusions: Our findings support the notion that constitutive activation of NF-kappaB and STAT3 depends on upstream signaling through PI3K, and that this activation is important for cell survival and proliferation, as well as for maintaining the level of Myc. Together, these data implicate crosstalk among NF-kappaB, STAT3 and PI3K in the development of iMyc E mu B-cell lymphomas.

Citing Articles

An immortalized adipose-derived stem cells line from the -related overgrowth spectrum: Unveiling novel therapeutic targets.

Sun B, Chen H, Gao W, Li Y, Hua C, Lin X Biochem Biophys Rep. 2024; 40:101869.

PMID: 39619655 PMC: 11605343. DOI: 10.1016/j.bbrep.2024.101869.


A miRNA-21-Mediated PTEN/Akt/NF-κB Axis Promotes Chronic Obstructive Pulmonary Disease Pathogenesis.

Sai X, Qin C, Zhang Z, Yu H, Bian T Int J Chron Obstruct Pulmon Dis. 2024; 19:1141-1151.

PMID: 38817823 PMC: 11137736. DOI: 10.2147/COPD.S453593.


Cynaropicrin disrupts tubulin and c-Myc-related signaling and induces parthanatos-type cell death in multiple myeloma.

Boulos J, Omer E, Rigano D, Formisano C, Chatterjee M, Leich E Acta Pharmacol Sin. 2023; 44(11):2265-2281.

PMID: 37344563 PMC: 10618500. DOI: 10.1038/s41401-023-01117-3.


Obesity and Risk for Lymphoma: Possible Role of Leptin.

Jimenez-Cortegana C, Hontecillas-Prieto L, Garcia-Dominguez D, Zapata F, Palazon-Carrion N, Sanchez-Leon M Int J Mol Sci. 2022; 23(24).

PMID: 36555171 PMC: 9779026. DOI: 10.3390/ijms232415530.


The Role of PD-L1 Expression in Prediction and Stratification of Recurrent or Refractory Extranodal Natural Killer/T-Cell Lymphoma.

Gao L, Zhang Y, Shi X, Liu Y, Wang J, Zhang W Front Oncol. 2022; 12:821918.

PMID: 35619907 PMC: 9128790. DOI: 10.3389/fonc.2022.821918.


References
1.
Murphy D, Junttila M, Pouyet L, Karnezis A, Shchors K, Bui D . Distinct thresholds govern Myc's biological output in vivo. Cancer Cell. 2008; 14(6):447-57. PMC: 2723751. DOI: 10.1016/j.ccr.2008.10.018. View

2.
Cantley L . The phosphoinositide 3-kinase pathway. Science. 2002; 296(5573):1655-7. DOI: 10.1126/science.296.5573.1655. View

3.
Bargou R, Emmerich F, Krappmann D, Bommert K, Mapara M, Arnold W . Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells. J Clin Invest. 1998; 100(12):2961-9. PMC: 508507. DOI: 10.1172/JCI119849. View

4.
Ohbayashi N, Ikeda O, Taira N, Yamamoto Y, Muromoto R, Sekine Y . LIF- and IL-6-induced acetylation of STAT3 at Lys-685 through PI3K/Akt activation. Biol Pharm Bull. 2007; 30(10):1860-4. DOI: 10.1248/bpb.30.1860. View

5.
Wu M, Lee H, Bellas R, Schauer S, Arsura M, Katz D . Inhibition of NF-kappaB/Rel induces apoptosis of murine B cells. EMBO J. 1996; 15(17):4682-90. PMC: 452200. View